Does Tigecycline Overdose Worsen Prognosis in Severe Infections?
No direct clinical evidence shows tigecycline overdose improves or worsens prognosis in severe infections like sepsis or ventilator-associated pneumonia. Tigecycline, a glycylcycline antibiotic, treats multidrug-resistant bacteria, but overdose primarily causes dose-dependent toxicities without proven impact on infection outcomes.[1]
Standard dosing is 100 mg IV loading, then 50 mg IV every 12 hours. Overdose reports (up to 10-fold excess) lead to nausea, vomiting, diarrhea, and elevated liver enzymes, but these resolve with supportive care like hemodialysis or charcoal hemoperfusion.[2][3] In severe infections, tigecycline's limited bactericidal activity and subtherapeutic lung penetration already correlate with higher mortality (18-25% in FDA warnings for complicated intra-abdominal infections).[4]
What Happens in Overdose Cases from Studies?
Case reports document overdoses in ICU patients with severe infections:
- A 72-year-old with pneumonia received 445 mg (9x dose); symptoms included acute kidney injury and transaminitis, managed conservatively; infection resolved with adjunct antibiotics, no mortality link to tigecycline.[5]
- Another case (1,400 mg total) in sepsis showed reversible liver failure; patient survived after filtration, with infection control unchanged.[6]
No studies link overdose serum levels (>2 mcg/mL) to worse survival rates versus therapeutic exposure (0.5-1 mcg/mL). Prognosis depends more on infection severity, comorbidities, and pathogen resistance.[1][7]
Why Might Overdose Not Affect Infection Prognosis?
Tigecycline overdose boosts peak concentrations temporarily but does not enhance efficacy due to time-dependent killing and protein binding (75-89%). Excess exposure mainly risks GI and hepatic toxicity, not direct antimicrobial failure.[3][8] In severe infections, underdosing (common in obesity) worsens outcomes more than overdose, per PK/PD models.[9]
How Is Overdose Managed in Severe Infection Patients?
Supportive: discontinue drug, monitor liver/kidney function, use activated charcoal for recent ingestion, or continuous venovenous hemodiafiltration (CVVHDF) for elimination (half-life 27-42 hours).[2][6] Avoid in pregnancy (Category D) due to fetal risks. No specific antidote exists.
When Does Overdose Risk Arise in Treatment?
Errors occur from dosing miscalculations in renal/hepatic impairment or obesity (adjust to 100 mg q12h). FDA label warns against overdose; monitor via therapeutic drug monitoring if available.[4][10]
[1]: FDA Tigecycline Label
[2]: Tigecycline Overdose Review, Clin Toxicol 2013
[3]: Case Report, J Med Toxicol 2015
[4]: FDA Warning on Mortality Risk
[5]: Overdose in Pneumonia, Ann Pharmacother 2009
[6]: Sepsis Overdose with CVVHDF, Ren Fail 2010
[7]: PK/PD in Severe Infections, J Antimicrob Chemother 2014
[8]: Tigecycline Pharmacology Review, Drugs 2005
[9]: Obesity Dosing Impact, Clin Infect Dis 2012
[10]: DrugPatentWatch.com - Tigecycline Patents